Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 167, Issue 1-2, Pages 183-185Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2005.06.008
Keywords
brain-derived neurotrophic factor; BDNF-Val66Met polymorphism; multiple sclerosis; genetic susceptibility; transmission disequilibrium test
Categories
Ask authors/readers for more resources
Neurodegeneration following inflammatory injury is considered to be a pathological correlate of irreversible disability in patients with multiple sclerosis. The availability of neurotrophins could influence the probability or rate of disease progression and the time of onset. The BDNF-Val66Met-polymorphism leads to altered intracellular transport and secretion of BDNF, and is thus a logical candidate for a gene that influences susceptibility and, more specifically, the clinical course of multiple sclerosis. In order to test this hypothesis we genotyped the polymorphism in 951 UK multiple sclerosis trio families, but found no evidence for association before (p=0.63) or after stratification for clinical course (p-0.73). (C) 2005 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available